title: Risk of pancreatic cancer in relation to ABO blood group and hepatitis C virus infection in Korea: a case-control study.
abstract: Several studies have reported that ABO blood group, hepatitis B virus (HBV) and hepatitis C virus (HCV) infection contribute to the development of pancreatic cancer. The aim of this study was to evaluate the association between these factors and pancreatic cancer in the Korean population. We retrospectively recruited 753 patients with pancreatic cancer and 3,012 healthy controls, matched 4 to 1 with cancer patients for age and sex, between 2001 and 2011, at the National Cancer Center, Korea. A multivariate logistic regression analysis was employed to estimate adjusted odds ratios (AORs). The AOR for pancreatic cancer in subjects with non-O blood types (A, AB, and B), compared to blood type O, was 1.29 (95% CI, 1.05-1.58; P = 0.01). Seropositivity for hepatitis B virus surface antigen was not significantly related to pancreatic cancer, either in univariate (odds ratio 1.03; 95% CI, 0.69-1.53; P = 0.91) or multivariate analysis (AOR, 1.02; 95% CI, 0.67-1.56; P = 0.93). The AOR for pancreatic cancer in subjects displaying seropositivity for anti-HCV was 2.30 (95% CI, 1.30-4.08; P < 0.01). Our results suggest that the non-O blood types and anti-HCV seropositivity, but not HBV infection, may increase the risk of developing pancreatic cancer in Korea, where HBV is endemic.
authors: Center for Liver Cancer, National Cancer Center, Goyang, Korea.
authors: Sang Myung
authors: SM
authors: Woo
authors: Jungnam
authors: J
authors: Joo
authors: Woo Jin
authors: WJ
authors: Lee
authors: Sang-Jae
authors: SJ
authors: Park
authors: Sung-Sik
authors: SS
authors: Han
authors: Tae Hyun
authors: TH
authors: Kim
authors: Young Hwan
authors: YH
authors: Koh
authors: Hyun Bum
authors: HB
authors: Kim
authors: Eun Kyung
authors: EK
authors: Hong
mesh_terms: D000017:ABO Blood-Group System; D000368:Aged; D016022:Case-Control Studies; D005260:Female; D006509:Hepatitis B / Q000150:complications / Q000175:diagnosis; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006526:Hepatitis C / Q000150:complications* / Q000175:diagnosis; D018937:Hepatitis C Antibodies / Q000097:blood; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D016017:Odds Ratio; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000209:etiology*; D056910:Republic of Korea; D012189:Retrospective Studies; D012307:Risk Factors
chemical_list: D000017:ABO Blood-Group System; D006514:Hepatitis B Surface Antigens; D018937:Hepatitis C Antibodies
keywords: ABO Blood-Group System; Hepatitis B Virus; Hepatitis C Virus; Korea; Pancreatic Neoplasms
references: Asian Pac J Cancer Prev. 2011;12(6):1405-8
references: 22126472
references: Liver Int. 2010 Mar;30(3):423-9
references: 19840258
references: J Natl Cancer Inst. 1987 Sep;79(3):425-34
references: 2442445
references: J Natl Cancer Inst. 2010 Apr 7;102(7):502-5
references: 20181960
references: J Natl Cancer Inst. 2010 Jan 20;102(2):135-7; author reply 137
references: 20019335
references: Dig Dis Sci. 2003 Aug;48(8):1648-53
references: 12924663
references: Nat Genet. 2009 Sep;41(9):986-90
references: 19648918
references: Lab Invest. 1984 Apr;50(4):394-400
references: 6368970
references: Br J Cancer. 2003 Aug 4;89(3):519-23
references: 12888824
references: J Korean Med Sci. 2010 Aug;25(8):1113-21
references: 20676319
references: J Natl Cancer Inst. 1974 May;52(5):1425-30
references: 4831434
references: Int J Cancer. 2011 Mar 1;128(5):1179-86
references: 20473916
references: Gastroenterol Clin North Am. 1999 Sep;28(3):673-85, x
references: 10503143
references: Int J Pancreatol. 1990 Mar;6(2):81-8
references: 2230362
references: Am J Hum Genet. 1970 Jul;22(4):464-75
references: 5432291
references: J Natl Cancer Inst. 2009 Mar 18;101(6):424-31
references: 19276450
references: Nat Rev Gastroenterol Hepatol. 2009 Dec;6(12):699-708
references: 19806144
references: Cancer Res. 1971 Sep;31(9):1244-50
references: 4940062
references: Mol Carcinog. 2012 Jan;51(1):109-18
references: 22162235
references: Br J Cancer. 2005 Jun 6;92(11):2076-83
references: 15886696
references: J Korean Med Sci. 2002 Aug;17(4):457-62
references: 12172038
references: Lancet. 2011 Aug 13;378(9791):607-20
references: 21620466
references: Ann N Y Acad Sci. 1999 Jun 30;880:191-200
references: 10415864
references: Cancer Sci. 2011 May;102(5):1076-80
references: 21306478
references: J Clin Oncol. 2008 Oct 1;26(28):4557-62
references: 18824707
references: Cancer Res. 2010 Feb 1;70(3):1015-23
references: 20103627
references: Gastroenterology. 1981 Dec;81(6):998-1005
references: 6169587
references: Gastroenterology. 1980 Aug;79(2):191-4
references: 7399225
references: Am J Epidemiol. 2010 Dec 1;172(11):1280-5
references: 20937632
references: Int J Cancer. 2012 Jul 15;131(2):461-8
references: 21858814
references: Cancer Res. 1988 Oct 1;48(19):5422-6
references: 3166398
references: World J Gastroenterol. 2005 Jun 21;11(23):3508-13
references: 15962364
references: Annu Rev Genomics Hum Genet. 2003;4:237-56
references: 14527303
references: Hepatology. 2009 Jan;49(1):116-23
references: 19085911
references: Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):359-64
references: 18268120
references: Br Med J. 1960 Apr 16;1(5180):1163-6
references: 13792191